Leo I. Gordon, MD

Experts discuss providing supportive care to patients receiving CAR T-cell therapy.

Leo I. Gordon, MD, and others discussed second-line treatment of diffuse large B-cell lymphoma.

Leo I. Gordon, MD, professor of medicine, Feinberg School of Medicine, Northwestern University, discusses the concerns of chimeric antigen receptor (CAR) T-cell therapy.